MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacadv.2026.103346

Медицинская библиотека · JACC. Advances · 2026

Systemic Inflammation and Adverse Heart Failure Outcomes: Insights From the Veterans Affairs Health Care System.

Sandhu Alexander T, Furst Adam, Varshney Anubodh S, Sallam Karim, Hsiao Stephanie, Gromovsky Anthony, Khachatourian Kat Wolf, Din Natasha, Skaar Jeffrey R, Tonnu-Mihara Ivy

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

The association between systemic inflammation (SI) and outcomes among patients with heart failure with preserved ejection fraction (HFpEF) or mildly reduced ejection fraction (HFmrEF) is uncertain.

OBJECTIVES

This study aimed to evaluate the association between SI and clinical and economic outcomes among individuals with HFpEF/HFmrEF.

METHODS

We identified Veterans with HFpEF/HFmrEF with outpatient high-sensitivity C-reactive protein (hsCRP) testing from 2008 to 2022. We classified Veterans as with SI (hsCRP 2-10 mg/L) and without SI (hsCRP <2 mg/L). The primary outcome was the 3-component major adverse cardiovascular event (MACE) outcome of death, HF hospitalization, and HF-related emergency department encounters. Additional outcomes included acute care utilization and costs. We evaluated the adjusted associations between SI and clinical outcomes, acute care utilization, and costs via Cox regression, negative binomial regression, and gamma regression, respectively.

RESULTS

We identified 49,986 Veterans with HFpEF/HFmrEF with outpatient hsCRP levels. We compared 8,696 (17.4%) Veterans without SI (hsCRP <2 mg/L) and 25,352 (50.7%) Veterans with SI (hsCRP ≥2 mg/L and ≤10 mg/L Over a median follow-up of 3.4 years (IQR: 1.8-5.8), MACE incidence was 15.1/100 patient-years (95% CI: 14.9-15.4) among those with SI vs 11.8/100 patient-years (95% CI: 11.4-12.1) among those without SI (P < 0.001). After adjustment, SI was associated with increased MACE (HR: 1.28; 95% CI: 1.24-1.33). SI was also associated with increased all-cause hospitalizations (incidence rate ratio: 1.19; 95% CI: 1.137-1.246) and $9,112 (95% CI: $6,135-$12,089) in additional per-patient costs over 1 year.

CONCLUSIONS

Among Veterans with HFmrEF/HFpEF, SI is associated with increased adverse clinical outcomes and higher costs.

Для цитирования: Sandhu Alexander T, Furst Adam, Varshney Anubodh S, Sallam Karim, Hsiao Stephanie, Gromovsky Anthony, Khachatourian Kat Wolf, Din Natasha, Skaar Jeffrey R, Tonnu-Mihara Ivy. Systemic Inflammation and Adverse Heart Failure Outcomes: Insights From the Veterans Affairs Health Care System.. JACC. Advances. 2026. DOI: 10.1016/j.jacadv.2026.103346.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.